Tag: Clinical

VCU Health leads clinical trial of new treatment to help people with bowel control issues

olivia torani A research team at VCU Health is leading a clinical trial evaluating new treatments for fecal incontinence and sudden loss of bowel control. The treatment involves implanting a bioengineered sphincter muscle derived from the patient’s natural cells to help the patient regain control of his or her bowels. The transplant surgery for the […]

BMS’ Opdivo regimen shows promise in colorectal cancer clinical trials

BMS’ Opdivo plus Yervoy significantly improved progression-free survival in patients with MSI-H/dMMR metastatic colorectal cancer. Credit: Bristol-Myers Squibb Company. bristol myers squib (BMS) is a Phase III CheckMate-8HW clinical trial combining Opdivo (nivolumab) and Yervoy (ipilimumab) as a first-line treatment option for microsatellite-high instability (MSI-H) or mismatch repair deficiency (dMMR). reported promising data. Metastatic colorectal […]

Bristol-Myers Squibb launches Kibosh into clinical trials for colorectal cancer candidate

Photo: Bristol-Myers Squibb Building in Munich / iStock Tati Campero Bristol-Myers Squibb is discontinuing a clinical trial studying a combination of Opdivo (nivolumab) and leratorimab, called Opdurag, in patients with stable microsatellite metastatic colorectal cancer. Data from a Phase III trial of the combination, known as Relativity-123, was reviewed by an independent data monitoring board […]

Lunit releases clinical study results offering insight into colon cancer prognosis

runit reported results from a Korean clinical study showing how its Lunit SCOPE IO tissue analysis software helped predict prognosis for patients with stage II-III colon cancer treated with curative surgery and adjuvant therapy. did. Lunit SCOPE IO is a deep learning-based tumor-infiltrating lymphocyte (TIL) analyzer consisting of two complementary learning models developed for cell […]

Oncolytics Biotech Inc. Announces Anal Cancer Cohort of Peraleolep and Atezolizumab Goblet Phase 1/2 Clinical Trial Meets Efficacy Criteria – November 9, 2023, 7:01 a.m. EST

Oncolytics Biotech Inc. announces positive interim results from the Phase 1/2 GOBLET trial evaluating the combination of perolep and atezolizumab in second-line patients with unresectable anal canal squamous cell carcinoma, led by Dirk Arnold, MD. It was announced that it was announced. Director of the Asklepios Oncology Center in Hamburg and principal investigator of the […]

Study: Some gastrointestinal diseases are closely linked to dementia – Clinical Daily News

People with digestive problems should take extra care to prevent dementia, a new study warns. That’s because certain gastrointestinal problems are associated with dementia, and some have a higher risk of developing dementia than others. Clinicians know about diseases of the digestive system. Affect It alters the gut microbiota and affects gut metabolites associated with […]

CureusWBC counts and CRP levels in clinical laboratory markers and imaging modalities in USG and CT abdomen: a retrospective …Introduction Acute appendicitis (AA) is the most common surgical emergency.Despite using various diagnostic parameters….17 hours ago

CureusWBC counts and CRP levels in clinical laboratory markers and imaging modalities in USG and CT abdomen: a retrospective …Introduction Acute appendicitis (AA) is the most common surgical emergency.Despite using various diagnostic parameters….17 hours ago

Appendicitis Disease Market: Regional Coverage, Drug Insights, Epidemiological Studies, Clinical Trial Evaluation, and Price Reimbursement

London, October 12, 2023 /PRNewswire/ — appendicitis disease It is a common disease caused by an inflamed appendix. According to NIH research, approximately 5 to 9 out of 100 people will develop the disorder at some point. Due to the high disease burden, effective diagnostic and therapeutic methods are urgently needed. Landscape of illness_insight_logo Appendicitis […]